Tag: <span>mesothelioma patient</span>

Home / mesothelioma patient
Post

Drug combination shows meaningful responses for malignant peritoneal mesothelioma patient

UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER HOUSTON – A phase II study led by researchers from The University of Texas MD Anderson Cancer Center found that treatment with atezolizumab and bevacizumab was well-tolerated and resulted in a 40% objective response rate in patients with advanced malignant peritoneal mesothelioma, rare cancer in the lining...